QuidelOrtho Corporation (QDEL) is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by a solid first-half 2024 performance and its continued spending on research and development (R&D), is expected to contribute further. However, headwinds due to data security threats and reimbursement policies persist. This Zacks Rank #3 (Hold) company has lost 42.6% year to date against 12.4% growth of the industry. The S&P 500 has witnessed 18.5% growth in the said ...